Tianying Jian
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Regulation of Appetite and Obesity, Biochemical Analysis and Sensing Techniques, Neuropeptides and Animal Physiology, Pancreatic function and diabetes, Chemical Synthesis and Analysis
Most-Cited Works
- → Regulation of Energy Homeostasis by Bombesin Receptor Subtype-3: Selective Receptor Agonists for the Treatment of Obesity(2010)87 cited
- → Synthesis and Antibacterial Activity of a Novel Class of 4‘-Substituted 16-Membered Ring Macrolides Derived from Tylosin(2004)36 cited
- → Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity(2010)29 cited
- → Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety(2014)26 cited
- → Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists(2010)24 cited
- → Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist(2010)23 cited
- → Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes(2015)23 cited
- → Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity(2010)21 cited
- → The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes(2012)18 cited
- → Development of a novel class of potent and selective FIXa inhibitors(2015)16 cited